A fascinating interview with Robert Bourla, the CEO of Pfizer. I really liked going through this interview word by word and looking to see if he expresses ANY CONFIDENCE AT ALL in MRNA technology. He does not. Everybody knows at this point that the vaccines have been a total disaster and have not worked. But the CEOs have been going along saying "great success, great success!"
Look at this answer to the question about MRNA and look how many times he says "they" He is completely ready to jump ship on MRNA. "I didn't want to do it, "they" convinced me. "they, they, they" It's unbelievable!

QUESTION: And I read that because I want to get a little into the weeds here and the mRNA technology. When you and your colleagues were trying to decide which route to go down, the traditional vaccine route or the mRNA route, you write that it was, quote, "most counterintuitive to go the mRNA route," and yet you went that route. Explain why.

DR. BOURLA:" It was counterintuitive because Pfizer was mustering on the table, had very good experience and expertise with multiple technologies that could give a vaccine, and the Novartis that some of the vaccines are, we were very good in doing that. Protein vaccines, we were very good in doing that and plus many other technologies.

mRNA was a technology, but we had less experience, only two years working on this, and actually, mRNA was a technology that never delivered a single product until that day, not vaccine, not any other medicine. So it was very counterintuitive, and I was surprised when they suggested to me that this is the way to go, and I questioned it. And I asked them to justify how can you say something like that, but they came, and they were very, very convinced that this is the right way to go.

They felt that the two years of work on mRNA since 2018 together with BioNTech to develop the flu vaccine made them believe that the technology is mature and we are at the cusp of delivering a product.

So they convinced me. I followed my instinct that they know what they are saying. They are very good, and we made this very difficult decision at that time."

TRANSLATION: THEY DON'T WORK

--
At the end of the interview, comes another question from the internet- asked thru the interviewer. Again, THE CEO OF PFIZER says this:

Q: This question comes also from Washington, D.C., from Marc Barbiere. He asks the question, "How will Pfizer adapt the mRNA technology to enhance preparedness for future threats?"

DR. BOURLA: "I think we should make sure that we adapt all technologies, and we are advancing many technologies. It's not clear that a future threat will be best handled with an mRNA technology or with a new type of technology that will be required and that will be way more tailored to this new threat.

So this is why I said before that what we need to do is to maintain our flexibility by maintaining a thriving life sciences ecosystem, and that's it's allows private. And we should not have any apprehension against the private sector when we understand that it was essential to save, let's say, the world right now.

But mRNA, I don't know if it will be for the next pandemic, but I know that it is a technology that has dramatic future. It's not panacea. It's not going to be the solution for every disease in the world, but we are just scratching the surface."

TRANSLATION: THEY DON'T WORK.